eXoZymes, Inc.
eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.28 | $0 | -$2M |
| 2025 Q4 | -0.32 | $0 | -$2M |
| 2025 Q3 | -0.27 | $0 | -$2M |
| 2025 Q2 | -0.28 | $0 | -$2M |
| 2025 Q1 | -0.22 | $0 | -$1M |
| 2024 Q4 | -0.45 | $0 | -$6M |
| 2024 Q3 |
| -0.20 |
| $0 |
| -$541,524 |
| 2024 Q2 | -0.17 | $0 | -$3M |